Skip to main content
. 2018 Jan 29;36(8):757–764. doi: 10.1200/JCO.2017.75.2170

Fig 3.

Fig 3.

Effect of baseline FKSI-DRS on OS (intent-to-treat population). DRS, Disease-Related Symptoms; FKSI, Functional Assessment of Cancer Therapy–Kidney Symptom Index; HR, hazard ratio; mo, month; OS, overall survival; QoL, quality of life.